The following data is part of a premarket notification filed by The Binding Site Group, Ltd. with the FDA for Spaplus.
Device ID | K100179 |
510k Number | K100179 |
Device Name: | SPAPLUS |
Classification | Complement C3, Antigen, Antiserum, Control |
Applicant | THE BINDING SITE GROUP, LTD. Los Angele, CA 90025 -7121 |
Contact | Jay Geller |
Correspondent | Jay Geller THE BINDING SITE GROUP, LTD. Los Angele, CA 90025 -7121 |
Product Code | CZW |
CFR Regulation Number | 866.5240 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2010-01-21 |
Decision Date | 2010-08-13 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
05051700017596 | K100179 | 000 |
05051700015578 | K100179 | 000 |